Charles River Laboratories Intl. Inc vs PPG Industries, Inc. — how do they compare? Charles River Laboratories Intl. Inc trades at $301.4 (market cap $14.23B), while PPG Industries, Inc. trades at $104.27 (market cap $23.44B). The key difference: PPG Industries, Inc. is the larger of the two by market cap, and PPG Industries, Inc. pays a 2.81% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and PPG Industries, Inc. for 68 Days on average.
| CRL | PPG | |
|---|---|---|
Market Cap | $14.23B | $23.44B |
Volume | 1,176,885 | 2,064,777 |
Sector | Health | Basic Materials |
52-Week High | $310.77 | $131.56 |
52-Week Low | $149.93 | $94.34 |
Typical Hold Time | 33 Days | 68 Days |
Enterprise Value | $17.06B | $29.31B |
Dividend Yield | — | 2.81% |
Signals from Pluang's Aura AI — not financial advice
CRL trades at $304.01, up 1.24% on the day, near the consensus price target of $305.50. The stock shows a bullish technical trend with strong analyst support (73% buy ratings) and has beaten EPS estimates for three consecutive quarters. However, fundamentals reveal challenges with negative net income margins and a high P/E ratio of 684.85, while recent news highlights a strategic growth plan targeting 5-7% revenue growth and $300 million in savings by 2030.
The outlook is cautiously optimistic given strong analyst sentiment and recent earnings beats, but high valuation and profitability concerns pose risks. Investment opportunity hinges on successful execution of the new growth strategy to improve margins, while key risks include persistent negative earnings, competitive pressures, and execution missteps in achieving long-term targets.
PPG Industries trades at $103.96, down 1.07% today, with mixed technical signals showing bearish momentum but neutral oscillators. The company maintains solid fundamentals with a P/E of 15.13, net income margin of 9.57%, and consistent dividend payments. Recent earnings show volatility with Q2 2026 missing expectations, while analyst consensus remains bullish with a $130 price target representing 25% upside potential.
PPG presents a balanced investment case with strong profitability metrics and analyst support, though near-term headwinds in automotive refinish and European markets create uncertainty. The stock's current valuation appears reasonable relative to historical levels, but investors should monitor Q3 2026 earnings on October 27 for confirmation of growth trajectory amid ongoing margin pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →